On May 12, 2020, Dr. Anthony Fauci, through the National Institute of Health (NIH), recommended the use of Veklury® (remdesivir) for patients diagnosed with severe COVID-19. The Food and Drug Administration (FDA), which is around 40 plus percent funded by drug companies, then authorized the use of remdesivir for EUA (emergency use authorization). EUA is a kind of license given as approval of something experimental; a drug allowed to be used during times of health emergency. However, this emergency “drug” or treatment, or even a vaccine, should only be “strongly recommended” (or mandated?) by the government if there are no other alternatives. In this case, it seems strange that there are several alternatives in which almost no government officials are willing to talk about or promote. This is a serious matter that we all should talk about and decent talking is what we all need to have a real solution to this obvious man-made problem.
Back then, remdesivir was an unapproved experimental drug. Now it is being manufactured by Gilead Sciences. However, what makes it dubious is that on the NIH Panel on COVID19 Treatment Guidelines, there were nine people who have financial ties with the maker of remdesivir, Gilead Sciences. Dr. Bryan Ardis, the doctor who did a lot of investigation on the use and the real effects of remdesivir, and other drugs, exposed these names and their connection to this company. According to Dr. Ardis, these are:
Rajesh Gandhi is on the advisory board of Gilead Sciences.
David Glidden is a consultant for Gilead Sciences.
Adaora Adimora is a consultant for Gilead Sciences and received research support from Gilead Sciences.
Eric Daar is a consultant for Gilead Sciences and recieves research support from Gilead Sciences.
Judith Aberg received research support from Gilead Sciences.
Jason Baker received research support from Gilead Sciences.
Susanna Naggie received research support from Gilead Sciences.
Pablo Tebas received research support from Gilead Sciences.
Roger Bedimo received an honoraria from Gilead Sciences.
The NIH knows that remdesivir is not safe to patients and it is not effective, according also to Dr. Ardis. During the study on 61 patients last year, majority of them suffered multiple-organ-dysfunction syndrome, septic shock, acute kidney injury, and hypotension. These are all serious health problems. It’s ironic that the American public still listens to liars like Dr. Fauci or Bill Gates even though our history paints a very gloomy picture because of these people. What’s more absurd is that so many doctors and government officials around the world have demonstrated their level of stupidity by blindly following the recommendations of these people. They’ve shut down the economy, waste their resources, wasted so many lives, and vaccinated their own people without actually reading the actual science behind it and without asking for evidence. This is how many politicians function, especially those who received money from Bill Gates and other’s fake foundations disguised as philanthropic organizations, deliberately designed to lobby for the interest of the biggest pharmaceutical companies and the elite behind the current eugenics program.
Meanwhile, Dr. Bryan Ardis revealed that in the 5-day study, there were 71% reported adverse events in which 21% is serious and in the 10-day study, 74% of the patients suffered adverse effects in which 35% is serious. Dr. Ardin also shared the FDA’s report on May of 2020 for the study GS-US-5773:
“In a randomized, open-label clinical trial (Study GS-US-540-5773) of remdesivir in 397 subjects with severe COVID-19 treated with remdesivir for 5 (n=200) or 10 days (n=197), adverse events were reported in 71% and 74% of subjects, respectively, serious adverse events were reported in 21% and 35% of subjects, respectively, and Grade=3 adverse events were reported in 31% and 43% of subjects, respectively. Nine (5%) subjects in the 5-day group and 20 (10%) subjects in the 10-day group discontinued treatment due to an adverse event. All cause mortality at Day 28 was 10% vs 13% in the 5- and 10-day treatment groups, respectively.”
Then, Dr. Ardis also added this data:
“May 2020 FDA Publication: “397 subjects with severe COVID-19 treated with remdesivir for 5 (n=200) or 10 days (n=197), adverse events were reported in 71% and 74% of subjects”
May 2020 FDA Publication: Nine (5%) subjects in the 5-day group and 20 (10%) subjects in the 10-day group discontinued treatment due to an adverse event.
May 2020 FDA Publication: Serious adverse events were reported in 21% and 35% of subjects, [in the 5 day and 10 day groups] respectively.
October 2020 FDA Publication: “Adverse reactions were reported in 33 (17%) subjects in the 5-day group and 40 (20%) subjects in the 10-day group.”
October 2020 FDA Publication: 3% of the 5 day group and 5% of the 10 day group discontinued treatment due to an adverse reaction.
October 2020 FDA Publication: Serious adverse reactions were reported in 2% and 2% of subjects in the 5 day and 10 groups respectively.”
According also to Dr. Ardis’ revelation, majority of the patients who took remdesivir suffer liver damage, kidney failure, and different forms of organ damage. Later on, the patients develop pulmonary edema in which their lungs will be filled and drowned with one’s own liquid. This is common not only in the studies but also in many hospitals around the world. Though, it seems totally impossible to point at remdesivir as one of the fatal drugs that are killing so-called COVID patients right now in hospitals as health workers are dominated by dogma; mainstream medicine is their religion. What’s worse is that in some countries like the Philippines, doctors, hospitals, and the government are in cahoots with one another in extracting huge amounts of money from the state health insurance by labeling patients as COVID patients even though in reality, they’re not. Therefore once and for all, this has to be stopped.
To read the full article on the study of remdesivir and Dr. Ardis’ interview, go to this link:
- Featured image: https://www.pennmedicine.org/updates/blogs/penn-physician-blog/2020/october/remdesivir-fda-approved-for-covid19